VRTX: To Present At Thomas Weisel Healthcare Conference @ 08:00 ET [delayed] -
Vertex Pharmaceuticals (VRTX) NewsBite - VRTX Could Be On the Move -
Vertex Pharmaceuticals Accelerates To Weekly High -
Vertex Pharmaceuticals Drops To 3-Week Low -
Vertex to initiate Phase III study of hepatitis drug -
Vertex Pharmaceuticals (VRTX) NewsBite - One Of Today's Top Losers So Far -
CORRECT: Vertex Pharma to begin Phase III trial -
Vertex Pharma in deal with U.S. and European regulators to begin Phase III trial -
Vertex Pharmaceuticals Breaks Support -
VRTX: To Present At Canaccord Adams Global Growth Conference @ 08:30 ET [delayed] -
Vertex Pharmaceuticals Picks Up Volume, Extends Losses -
VRTX: To Present At BMO Focus on Healthcare Conference @ 09:00 ET [delayed] -
VRTX: To Present At IBC Life Sciences DDT 2008 Conference @ 11:30 ET [delayed] -
VRTX: To Present At IBC Life Sciences DDT 2008 Conference @ 11:15 ET [delayed] -
Vertex Pharmaceuticals Highlights Telaprevir Progress and Reports Second Quarter 2008 Results -
VRTX: Q2 Earnings Call @ 17:00 ET Today [delayed] -